Home Blog Page 3

Checking in on Fortive Corporation (FTV) after recent insiders movement

Fortive Corporation’s recent filing unveils that its President & CEO of AHS Murphy Patrick K unloaded Company’s shares for reported $2.25 million on Nov 11. In the deal valued at $68.56 per share,32,788 shares were sold. As a result of this transaction, Murphy Patrick K now holds 62,929 shares worth roughly $4.23 million.

Then, McLaughlin Charles E sold 13,156 shares, generating $900,397 in total proceeds. Upon selling the shares at $68.44, the SVP – Chief Financial Officer now owns 88,818 shares.

Before that, SPOON ALAN G bought 17,400 shares. Fortive Corporation shares valued at $1,013,493 were divested by the Director at a price of $58.25 per share. As a result of the transaction, SPOON ALAN G now holds 98,861 shares, worth roughly $6.65 million.

Morgan Stanley upgraded its Fortive Corporation [FTV] rating to an Overweight from a an Equal-weight in a research note published on Monday, October 12, 2022; the price target was increased to $73 from $68. PT values the company’s stock at a premium of 7.92 to its Monday closing price. A number of analysts have revised their coverage, including Argus’s analysts, who increased its forecast for the stock in mid March from “a Hold” to “a Buy”. Barclays also remained covering FTV and has increased its forecast on March 14, 2022 with a “an Overweight” recommendation from previously “an Equal weight” rating. Vertical Research revised its rating on January 03, 2022. It rated FTV as “a Hold” which previously was an “a Buy”.

Price Performance Review of FTV

On Monday, Fortive Corporation [NYSE:FTV] saw its stock fall -1.49% to $67.22. On the same session, the stock had its day’s lowest price of $66.698, but rose to a high of $67.60. Over the last five days, the stock has gained 2.39%. Fortive Corporation shares have fallen nearly -11.89% since the year began. Nevertheless, the stocks have fallen -9.81% over the past one year. While a 52-week high of $76.93 was reached on 01/03/22, a 52-week low of $52.47 was recorded on 07/14/22. SMA at 50 days reached $63.45, while 200 days put it at $61.29. A total of 1.51 million shares were traded, compared to the trading of 1.36 million shares in the previous session.

Levels Of Support And Resistance For FTV Stock

The 24-hour chart illustrates a support level at 66.75, which if violated will result in even more drops to 66.27. On the upside, there is a resistance level at 67.65. A further resistance level may holdings at 68.07. The Relative Strength Index (RSI) on the 14-day chart is 55.91, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.65, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 32.45%. Stochastics %K at 75.44% indicates the stock is a holding.

How much short interest is there in Fortive Corporation?

A steep rise in short interest was recorded in Fortive Corporation stocks on Oct 13, 2022, growing by 0.34 million shares to a total of 5.39 million shares. Yahoo Finance data shows the prior-month short interest on Sep 14, 2022 was 5.05 million shares. There was a rise of 6.31%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 1.69% of the overall stock float, the days-to-cover ratio (short ratio) rose to 2.99.

Fortive Corporation [FTV] – Who Are The Largest Shareholders?

In filings from T. Rowe Price Investment Manageme, it is revealed that the company now owns 41,619,139 shares, or roughly 11.76% of the outstanding FTV shares. Additionally, The Vanguard Group, Inc. decreased -0.13% of its stake after which the total value it holdings stand at $2,418,819,033, while Wellington Management Co. LLP reduced -4.12% of its stake to hold $1.18 billion in the firm. Over the last quarter, BlackRock Fund Advisors sold -23,209 shares of Fortive Corporation, while RBC Global Asset Management sold -47,547 shares. At present, SSgA Funds Management, Inc. is holding 13,357,416 shares valued at $853.54 million. Flossbach von Storch AG owned 12,696,874 shares of the company at the time of its most recent 13F filing, worth $811.33 million.

According to FactSet, Fortive Corporation’s share price will average $73.07 in the next year, based on opinions of analysts polled by the firm. This is up nearly 6.98 percent from its previous closing price of $68.24. Analysts expect Fortive Corporation stock to reach the higher price of $85.00, while the lowest price estimate is $60.00. However, 22 analysts have rated FTV stock as an Overweight in their predictions for 2022. The most recent change occurred on December 17, 2021 when Mizuho began covering the stock and recommended ‘”a Neutral”‘ rating along with a $82 price target.

Investing in CONSOL Energy Inc. (CEIX) Is Getting More Attractive

In a filing, CONSOL Energy Inc. revealed its Chief Executive Officer Brock James A unloaded Company’s shares for reported $39100.0 on Dec 01. In the deal valued at $78.20 per share,500 shares were sold. As a result of this transaction, Brock James A now holds 473,020 shares worth roughly $33.91 million.

Then, Brock James A sold 3,314 shares, generating $258,757 in total proceeds. Upon selling the shares at $78.08, the Chief Executive Officer now owns 473,520 shares.

Before that, Brock James A sold 12,500 shares. CONSOL Energy Inc. shares valued at $941,625 were divested by the Chief Executive Officer at a price of $75.33 per share. As a result of the transaction, Brock James A now holds 476,834 shares, worth roughly $34.18 million.

The Benchmark Company reiterated its CONSOL Energy Inc. [CEIX] rating to a Buy in a research note published on Monday, July 14, 2020; the price target was $7. PT values the company’s stock at a premium of -924.0 to its Monday closing price. A number of analysts have revised their coverage, including The Benchmark Company’s analysts, who began to cover the stock in mid February with a ‘”a Buy”‘ rating. Stifel maintained its rating on February 08, 2018. It rated CEIX as “a Buy”.

Price Performance Review of CEIX

On Monday, CONSOL Energy Inc. [NYSE:CEIX] saw its stock fall -4.81% to $71.68. On the same session, the stock had its day’s lowest price of $70.20, but rose to a high of $77.22. Over the last five days, the stock has gained 2.30%. CONSOL Energy Inc. shares have risen nearly 220.25% since the year began. Nevertheless, the stocks have risen 236.40% over the past one year. While a 52-week high of $79.17 was reached on 08/26/22, a 52-week low of $18.83 was recorded on 01/24/22. SMA at 50 days reached $66.20, while 200 days put it at $55.19. A total of 0.58 million shares were traded, compared to the trading of 0.75 million shares in the previous session.

Levels Of Support And Resistance For CEIX Stock

The 24-hour chart illustrates a support level at 68.85, which if violated will result in even more drops to 66.01. On the upside, there is a resistance level at 75.87. A further resistance level may holdings at 80.05. The Relative Strength Index (RSI) on the 14-day chart is 56.47, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 5.22, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 33.52%. Stochastics %K at 74.71% indicates the stock is a holding.

How much short interest is there in CONSOL Energy Inc.?

A steep rise in short interest was recorded in CONSOL Energy Inc. stocks on Oct 13, 2022, growing by 90000.0 shares to a total of 2.17 million shares. Yahoo Finance data shows the prior-month short interest on Sep 14, 2022 was 2.08 million shares. There was a rise of 4.15%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 7.46% of the overall stock float, the days-to-cover ratio (short ratio) rose to 4.08.

CONSOL Energy Inc. [CEIX] – Who Are The Largest Shareholders?

In filings from BlackRock Fund Advisors, it is revealed that the company now owns 4,798,133 shares, or roughly 13.76% of the outstanding CEIX shares. In other words, the investor’s shares have fallen by -47,556 from its previous 13-F filing of 4845689.0. Additionally, SSgA Funds Management, Inc. decreased -13.64% of its stake after which the total value it holdings stand at $134,888,575, while The Vanguard Group, Inc. added 11.83% of its stake to hold $134.32 million in the firm. Over the last quarter, Dimensional Fund Advisors LP sold -13,147 shares of CONSOL Energy Inc., while AzValor Asset Management SGIIC SA sold -1,499,762 shares. At present, Greenlight Capital, Inc. is holding 1,712,721 shares valued at $107.94 million. Fidelity Management & Research Co owned 1,242,299 shares of the company at the time of its most recent 13F filing, worth $78.29 million.

According to FactSet, CONSOL Energy Inc.’s share price will average $80.00 in the next year, based on opinions of analysts polled by the firm. This is up nearly 6.24 percent from its previous closing price of $75.30. Analysts expect CONSOL Energy Inc. stock to reach the higher price of $85.00, while the lowest price estimate is $75.00. However, 3 analysts have rated CEIX stock as a Buy in their predictions for 2022.

Investing in NGL Energy Partners LP (NGL): What You Must Know

0

NGL Energy Partners LP’s filing revealed that its Director COLLINGSWORTH JAMES M acquired Company’s shares for reported $57965.0 on Dec 02. In the deal valued at $1.16 per share,50,000 shares were bought. As a result of this transaction, COLLINGSWORTH JAMES M now holds 404,500 shares worth roughly $0.46 million.

Then, KRIMBILL H MICHAEL bought 100,000 shares, generating $126,900 in total proceeds. Upon buying the shares at $1.27, the Chief Executive Officer now owns 2,788,615 shares.

Before that, KRIMBILL H MICHAEL bought 100,000 shares. NGL Energy Partners LP shares valued at $128,210 were divested by the Chief Executive Officer at a price of $1.28 per share. As a result of the transaction, KRIMBILL H MICHAEL now holds 2,688,615 shares, worth roughly $3.04 million.

UBS upgraded its NGL Energy Partners LP [NGL] rating to a Neutral from a a Sell in a research note published on Monday, February 18, 2021; the price target was increased to $3 from $2. PT values the company’s stock at a premium of 62.33 to its Monday closing price. A number of analysts have revised their coverage, including UBS’s analysts, who decreased its forecast for the stock in mid October from “a Neutral” to “a Sell”. Wells Fargo also remained covering NGL and has decreased its forecast on July 22, 2020 with a “an Underweight” recommendation from previously “an Equal weight” rating. Credit Suisse revised its rating on April 02, 2020. It rated NGL as “an Underperform” which previously was an “a Neutral”.

Price Performance Review of NGL

On Monday, NGL Energy Partners LP [NYSE:NGL] saw its stock fall -2.59% to $1.13. On the same session, the stock had its day’s lowest price of $1.13, but rose to a high of $1.1614. Over the last five days, the stock has lost -8.87%. NGL Energy Partners LP shares have fallen nearly -37.91% since the year began. Nevertheless, the stocks have fallen -43.50% over the past one year. While a 52-week high of $2.80 was reached on 02/04/22, a 52-week low of $1.13 was recorded on 12/05/22. SMA at 50 days reached $1.3022, while 200 days put it at $1.7159. A total of 0.52 million shares were traded, compared to the trading of 1.02 million shares in the previous session.

Levels Of Support And Resistance For NGL Stock

The 24-hour chart illustrates a support level at 1.1195, which if violated will result in even more drops to 1.1091. On the upside, there is a resistance level at 1.1509. A further resistance level may holdings at 1.1719. The Relative Strength Index (RSI) on the 14-day chart is 30.83, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0869, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 100.00%. Stochastics %K at 8.35% indicates the stock is a buying.

How much short interest is there in NGL Energy Partners LP?

A steep rise in short interest was recorded in NGL Energy Partners LP stocks on Oct 13, 2022, growing by 13600.0 shares to a total of 0.47 million shares. Yahoo Finance data shows the prior-month short interest on Sep 14, 2022 was 0.46 million shares. There was a rise of 2.89%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 0.54% of the overall stock float, the days-to-cover ratio (short ratio) rose to 1.46.

NGL Energy Partners LP [NGL] – Who Are The Largest Shareholders?

In filings from Invesco Advisers, Inc., it is revealed that the company now owns 19,717,009 shares, or roughly 15.09% of the outstanding NGL shares. Over the last quarter, Goldman Sachs & Co. LLC purchased 221,301 shares of NGL Energy Partners LP, while GSA Capital Partners LLP bought 178,252 shares. At present, Wells Fargo Bank, NA is holding 391,843 shares valued at $0.54 million. NBW Capital LLC owned 285,628 shares of the company at the time of its most recent 13F filing, worth $0.39 million.

According to FactSet, NGL Energy Partners LP’s share price will average $2.00 in the next year, based on opinions of analysts polled by the firm. This is up nearly 72.41 percent from its previous closing price of $1.16. Analysts expect NGL Energy Partners LP stock to reach the higher price of $2.00, while the lowest price estimate is $2.00. However, 2 analysts have rated NGL stock as an Underweight in their predictions for 2022.

Is it a good time to sell Tripadvisor Inc. [TRIP] shares after an insider sold 4,274 shares?

0

Tripadvisor Inc.’s recently made public that its Chief Accounting Officer Gouvalaris Geoffrey unloaded Company’s shares for reported $99516.0 on Sep 06. In the deal valued at $23.28 per share,4,274 shares were sold. As a result of this transaction, Gouvalaris Geoffrey now holds 26,551 shares worth roughly $0.52 million.

Then, TEUNISSEN ERNST 02494 sold 15,000 shares, generating $412,500 in total proceeds. Upon selling the shares at $27.50, the Chief Financial Officer now owns 33,523 shares.

Before that, MAFFEI GREGORY B bought 50,000 shares. Tripadvisor Inc. shares valued at $1,119,084 were divested by the Director at a price of $22.38 per share. As a result of the transaction, MAFFEI GREGORY B now holds 92,448 shares, worth roughly $1.81 million.

Citigroup downgraded its Tripadvisor Inc. [TRIP] rating to a Neutral from a a Buy in a research note published on Monday, April 20, 2022; the price target was decreased to $30 from $39. PT values the company’s stock at a premium of 34.73 to its Monday closing price. UBS began covering TRIP with “Neutral” recommendation on December 02, 2021. Barclays revised its rating on November 01, 2021. It rated TRIP as “an Underweight” which previously was an “an Overweight”.

Price Performance Review of TRIP

On Monday, Tripadvisor Inc. [NASDAQ:TRIP] saw its stock fall -3.59% to $19.58. On the same session, the stock had its day’s lowest price of $19.515, but rose to a high of $20.3794. Over the last five days, the stock has gained 0.67%. Tripadvisor Inc. shares have fallen nearly -28.17% since the year began. Nevertheless, the stocks have fallen -20.89% over the past one year. While a 52-week high of $30.48 was reached on 02/11/22, a 52-week low of $16.87 was recorded on 07/15/22. SMA at 50 days reached $22.04, while 200 days put it at $23.12. A total of 1.32 million shares were traded, compared to the trading of 1.16 million shares in the previous session.

Levels Of Support And Resistance For TRIP Stock

The 24-hour chart illustrates a support level at 19.27, which if violated will result in even more drops to 18.96. On the upside, there is a resistance level at 20.13. A further resistance level may holdings at 20.69. The Relative Strength Index (RSI) on the 14-day chart is 40.21, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.18, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 74.14%. Stochastics %K at 38.75% indicates the stock is a holding.

How much short interest is there in Tripadvisor Inc.?

A steep rise in short interest was recorded in Tripadvisor Inc. stocks on Oct 13, 2022, growing by 0.62 million shares to a total of 13.06 million shares. Yahoo Finance data shows the prior-month short interest on Sep 14, 2022 was 12.44 million shares. There was a rise of 4.75%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 12.13% of the overall stock float, the days-to-cover ratio (short ratio) rose to 7.87.

Tripadvisor Inc. [TRIP] – Who Are The Largest Shareholders?

In filings from The Vanguard Group, Inc., it is revealed that the company now owns 10,137,688 shares, or roughly 7.98% of the outstanding TRIP shares. In other words, the investor’s shares have risen by 567,048 from its previous 13-F filing of 9570640.0. Additionally, PAR Capital Management, Inc. decreased -19.35% of its stake after which the total value it holdings stand at $212,745,340, while BlackRock Fund Advisors added 1.40% of its stake to hold $185.73 million in the firm. Over the last quarter, Select Equity Group LP purchased 2,325,143 shares of Tripadvisor Inc., while Polar Capital LLP bought 991,577 shares. At present, FIL Investment Advisors is holding 4,130,929 shares valued at $97.57 million. Maple Rock Capital Partners, Inc. owned 3,386,340 shares of the company at the time of its most recent 13F filing, worth $79.99 million.

According to FactSet, Tripadvisor Inc.’s share price will average $26.14 in the next year, based on opinions of analysts polled by the firm. This is up nearly 15.71 percent from its previous closing price of $20.31. Analysts expect Tripadvisor Inc. stock to reach the higher price of $40.00, while the lowest price estimate is $17.00. However, 19 analysts have rated TRIP stock as a Hold in their predictions for 2022.

Stankovic Srdjan R. divested 27834.0 US dollars’ worth of ACADIA Pharmaceuticals Inc. [ACAD] stock.

ACADIA Pharmaceuticals Inc.’s recent filing unveils that its President Stankovic Srdjan R. unloaded Company’s shares for reported $27834.0 on Nov 21. In the deal valued at $15.07 per share,1,847 shares were sold. As a result of this transaction, Stankovic Srdjan R. now holds 61,234 shares worth roughly $0.93 million.

Then, Stankovic Srdjan R. sold 1,326 shares, generating $20,964 in total proceeds. Upon selling the shares at $15.81, the President now owns 56,831 shares.

Before that, DAVIS STEPHEN sold 2,804 shares. ACADIA Pharmaceuticals Inc. shares valued at $44,331 were divested by the CEO at a price of $15.81 per share. As a result of the transaction, DAVIS STEPHEN now holds 79,009 shares, worth roughly $1.2 million.

Goldman downgraded its ACADIA Pharmaceuticals Inc. [ACAD] rating to a Sell from a a Neutral in a research note published on Monday, November 04, 2022; the price target was decreased to $12 from $15. PT values the company’s stock at a premium of -27.0 to its Monday closing price. A number of analysts have revised their coverage, including Loop Capital’s analysts, who began to cover the stock in early November with a ‘”a Hold”‘ rating. Citigroup also remained covering ACAD and has decreased its forecast on August 08, 2022 with a “Neutral” recommendation from previously “Buy” rating. Citigroup revised its rating on August 05, 2022. It rated ACAD as “a Neutral” which previously was an “a Buy”.

Price Performance Review of ACAD

On Monday, ACADIA Pharmaceuticals Inc. [NASDAQ:ACAD] saw its stock fall -3.30% to $15.24. On the same session, the stock had its day’s lowest price of $15.055, but rose to a high of $15.63. Over the last five days, the stock has gained 3.18%. ACADIA Pharmaceuticals Inc. shares have fallen nearly -34.70% since the year began. Nevertheless, the stocks have fallen -23.57% over the past one year. While a 52-week high of $28.06 was reached on 04/07/22, a 52-week low of $12.24 was recorded on 06/21/22. SMA at 50 days reached $15.82, while 200 days put it at $18.16. A total of 1.08 million shares were traded, compared to the trading of 0.72 million shares in the previous session.

Levels Of Support And Resistance For ACAD Stock

The 24-hour chart illustrates a support level at 14.99, which if violated will result in even more drops to 14.73. On the upside, there is a resistance level at 15.56. A further resistance level may holdings at 15.88. The Relative Strength Index (RSI) on the 14-day chart is 48.06, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.28, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 63.66%. Stochastics %K at 45.52% indicates the stock is a holding.

How much short interest is there in ACADIA Pharmaceuticals Inc.?

A steep rise in short interest was recorded in ACADIA Pharmaceuticals Inc. stocks on Oct 13, 2022, dropping by 80000.0 shares to a total of 9.52 million shares. Yahoo Finance data shows the prior-month short interest on Sep 14, 2022 was 9.6 million shares. There was a decline of -0.84%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 7.96% of the overall stock float, the days-to-cover ratio (short ratio) fell to 5.93.

ACADIA Pharmaceuticals Inc. [ACAD] – Who Are The Largest Shareholders?

In filings from Baker Bros. Advisors LP, it is revealed that the company now owns 41,923,486 shares, or roughly 25.90% of the outstanding ACAD shares. Additionally, The Vanguard Group, Inc. increased 4.30% of its stake after which the total value it holdings stand at $202,162,040, while Fidelity Management & Research Co reduced -6.68% of its stake to hold $185.48 million in the firm. Over the last quarter, BlackRock Fund Advisors purchased 27,328 shares of ACADIA Pharmaceuticals Inc., while SSgA Funds Management, Inc. bought 184,921 shares. At present, Ecor1 Capital LLC is holding 5,991,479 shares valued at $96.04 million. T. Rowe Price Associates, Inc. owned 4,891,348 shares of the company at the time of its most recent 13F filing, worth $78.41 million.

According to FactSet, ACADIA Pharmaceuticals Inc.’s share price will average $18.50 in the next year, based on opinions of analysts polled by the firm. This is up nearly 11.04 percent from its previous closing price of $15.76. Analysts expect ACADIA Pharmaceuticals Inc. stock to reach the higher price of $25.00, while the lowest price estimate is $10.00. However, 21 analysts have rated ACAD stock as a Hold in their predictions for 2022.

Latest Insider moments: GHAI RAHUL, Otis Worldwide Corporation [OTIS] EVP, CFO sold 5,000 shares

0

In a filing, Otis Worldwide Corporation revealed its EVP, CFO GHAI RAHUL unloaded Company’s shares for reported $0.39 million on Aug 02. In the deal valued at $77.87 per share,5,000 shares were sold. As a result of this transaction, GHAI RAHUL now holds 2,063 shares worth roughly $0.16 million.

Then, GHAI RAHUL sold 2,618 shares, generating $205,631 in total proceeds. Upon selling the shares at $78.55, the EVP, CFO now owns 7,063 shares.

Before that, LaFreniere Nora E. sold 13,576 shares. Otis Worldwide Corporation shares valued at $1,039,126 were divested by the EVP, General Counsel at a price of $76.54 per share. As a result of the transaction, LaFreniere Nora E. now holds 12,376 shares, worth roughly $0.97 million.

Barclays downgraded its Otis Worldwide Corporation [OTIS] rating to an Equal weight from a an Overweight in a research note published on Monday. PT values the company’s stock at a premium of 1.9 to its Monday closing price. A number of analysts have revised their coverage, including Argus’s analysts, who decreased its forecast for the stock in early November from “a Buy” to “a Hold”. JP Morgan also remained covering OTIS and has decreased its forecast on July 07, 2022 with a “Neutral” recommendation from previously “an Overweight” rating. Exane BNP Paribas revised its rating on July 05, 2022. It rated OTIS as “a Neutral” which previously was an “an Outperform”.

Price Performance Review of OTIS

On Monday, Otis Worldwide Corporation [NYSE:OTIS] saw its stock fall -1.59% to $78.48. On the same session, the stock had its day’s lowest price of $77.84, but rose to a high of $79.26. Over the last five days, the stock has gained 2.80%. Otis Worldwide Corporation shares have fallen nearly -9.87% since the year began. Nevertheless, the stocks have fallen -5.22% over the past one year. While a 52-week high of $88.22 was reached on 01/03/22, a 52-week low of $62.49 was recorded on 10/13/22. SMA at 50 days reached $71.11, while 200 days put it at $73.48. A total of 2.04 million shares were traded, compared to the trading of 2.0 million shares in the previous session.

Levels Of Support And Resistance For OTIS Stock

The 24-hour chart illustrates a support level at 77.79, which if violated will result in even more drops to 77.11. On the upside, there is a resistance level at 79.21. A further resistance level may holdings at 79.95. The Relative Strength Index (RSI) on the 14-day chart is 61.44, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.89, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 36.21%. Stochastics %K at 77.74% indicates the stock is a holding.

How much short interest is there in Otis Worldwide Corporation?

A steep rise in short interest was recorded in Otis Worldwide Corporation stocks on Oct 13, 2022, dropping by -0.55 million shares to a total of 7.12 million shares. Yahoo Finance data shows the prior-month short interest on Sep 14, 2022 was 7.67 million shares. There was a decline of -7.72%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 1.70% of the overall stock float, the days-to-cover ratio (short ratio) fell to 3.58.

Otis Worldwide Corporation [OTIS] – Who Are The Largest Shareholders?

In filings from The Vanguard Group, Inc., it is revealed that the company now owns 38,083,283 shares, or roughly 9.14% of the outstanding OTIS shares. In other words, the investor’s shares have risen by 140,603 from its previous 13-F filing of 37942680.0. Additionally, BlackRock Fund Advisors decreased -1.06% of its stake after which the total value it holdings stand at $1,413,861,649, while SSgA Funds Management, Inc. reduced -1.20% of its stake to hold $1.13 billion in the firm. Over the last quarter, Fiera Capital Corp. sold -538,228 shares of Otis Worldwide Corporation, while Geode Capital Management LLC sold 146,700 shares. At present, AllianceBernstein LP is holding 9,637,299 shares valued at $680.78 million. Morgan Stanley Investment Managem owned 9,451,794 shares of the company at the time of its most recent 13F filing, worth $667.67 million.

According to FactSet, Otis Worldwide Corporation’s share price will average $79.00 in the next year, based on opinions of analysts polled by the firm. This is up nearly 0.31 percent from its previous closing price of $79.75. Analysts expect Otis Worldwide Corporation stock to reach the higher price of $90.00, while the lowest price estimate is $65.00. However, 14 analysts have rated OTIS stock as an Overweight in their predictions for 2022.

Insider Selling Buzz: Altair Engineering Inc. [ALTR] Chief Revenue Officer Dias Nelson sold 4,000 shares of the company

0

Altair Engineering Inc.’s filing revealed that its Chief Revenue Officer Dias Nelson unloaded Company’s shares for reported $0.19 million on Nov 23. In the deal valued at $47.11 per share,4,000 shares were sold. As a result of this transaction, Dias Nelson now holds 30,124 shares worth roughly $1.45 million.

Then, Scapa James Ralph sold 19,262 shares, generating $953,893 in total proceeds. Upon selling the shares at $49.52, the Chief Executive Officer now owns 83,962 shares.

Before that, Scapa James Ralph sold 57,915 shares. Altair Engineering Inc. shares valued at $2,894,128 were divested by the Chief Executive Officer at a price of $49.97 per share. As a result of the transaction, Scapa James Ralph now holds 103,224 shares, worth roughly $4.97 million.

Needham initiated its Altair Engineering Inc. [ALTR] rating to a Buy in a research note published on Monday, November 16, 2022; the price target was $60. PT values the company’s stock at a premium of 19.73 to its Monday closing price. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in mid August with a ‘”an Outperform”‘ rating. Oppenheimer began covering ALTR with “an Outperform” recommendation on July 27, 2022. Goldman revised its rating on June 27, 2022. It rated ALTR as “a Sell” which previously was an “a Neutral”.

Price Performance Review of ALTR

On Monday, Altair Engineering Inc. [NASDAQ:ALTR] saw its stock fall -3.45% to $48.16. On the same session, the stock had its day’s lowest price of $47.87, but rose to a high of $49.54. Over the last five days, the stock has gained 3.30%. Altair Engineering Inc. shares have fallen nearly -37.71% since the year began. Nevertheless, the stocks have fallen -32.76% over the past one year. While a 52-week high of $78.38 was reached on 01/03/22, a 52-week low of $43.17 was recorded on 10/13/22. SMA at 50 days reached $46.89, while 200 days put it at $53.48. A total of 0.7 million shares were traded, compared to the trading of 0.16 million shares in the previous session.

Levels Of Support And Resistance For ALTR Stock

The 24-hour chart illustrates a support level at 47.51, which if violated will result in even more drops to 46.85. On the upside, there is a resistance level at 49.18. A further resistance level may holdings at 50.19. The Relative Strength Index (RSI) on the 14-day chart is 51.71, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.49, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 43.14%. Stochastics %K at 78.37% indicates the stock is a holding.

How much short interest is there in Altair Engineering Inc.?

A steep rise in short interest was recorded in Altair Engineering Inc. stocks on Oct 13, 2022, dropping by 50000.0 shares to a total of 2.57 million shares. Yahoo Finance data shows the prior-month short interest on Sep 14, 2022 was 2.62 million shares. There was a decline of -1.95%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 5.96% of the overall stock float, the days-to-cover ratio (short ratio) fell to 7.

Altair Engineering Inc. [ALTR] – Who Are The Largest Shareholders?

In filings from Matrix Capital Management Co. LP, it is revealed that the company now owns 10,305,000 shares, or roughly 19.74% of the outstanding ALTR shares. In other words, the investor’s shares have risen by 1,005,000 from its previous 13-F filing of 9300000.0. Additionally, The Vanguard Group, Inc. increased 1.59% of its stake after which the total value it holdings stand at $232,683,586, while Pictet Asset Management SA reduced -2.45% of its stake to hold $177.9 million in the firm. Over the last quarter, BlackRock Fund Advisors sold -98,353 shares of Altair Engineering Inc., while Impax Asset Management Ltd. sold 312,662 shares. At present, Conestoga Capital Advisors LLC is holding 2,340,282 shares valued at $114.79 million. BAMCO, Inc. owned 1,634,730 shares of the company at the time of its most recent 13F filing, worth $80.18 million.

According to FactSet, Altair Engineering Inc.’s share price will average $56.88 in the next year, based on opinions of analysts polled by the firm. This is up nearly 20.29 percent from its previous closing price of $49.88. Analysts expect Altair Engineering Inc. stock to reach the higher price of $63.00, while the lowest price estimate is $39.00. However, 10 analysts have rated ALTR stock as an Overweight in their predictions for 2022. The most recent change occurred on November 09, 2021 when Loop Capital began covering the stock and recommended ‘”a Buy”‘ rating along with a $95 price target.

President-Drilling Subsidiary, Holcomb James Michael sold 58,335 shares of Patterson-UTI Energy Inc. [PTEN]

Patterson-UTI Energy Inc.’s recently made public that its President-Drilling Subsidiary Holcomb James Michael unloaded Company’s shares for reported $1.09 million on Nov 04. In the deal valued at $18.65 per share,58,335 shares were sold. As a result of this transaction, Holcomb James Michael now holds 273,108 shares worth roughly $4.45 million.

Then, Holcomb James Michael sold 16,666 shares, generating $266,823 in total proceeds. Upon selling the shares at $16.01, the President-Drilling Subsidiary now owns 331,443 shares.

Before that, Holcomb James Michael sold 8,333 shares. Patterson-UTI Energy Inc. shares valued at $133,328 were divested by the President-Drilling Subsidiary at a price of $16.00 per share. As a result of the transaction, Holcomb James Michael now holds 348,109 shares, worth roughly $5.68 million.

PT values the company’s stock at a premium of 14.16 to its Monday closing price. A number of analysts have revised their coverage, including BofA Securities’s analysts, who decreased its forecast for the stock in mid July from “a Buy” to “a Neutral”. Piper Sandler also remained covering PTEN and has decreased its forecast on June 01, 2022 with a “Neutral” recommendation from previously “an Overweight” rating. JP Morgan revised its rating on May 26, 2022. It rated PTEN as “a Neutral” which previously was an “an Underweight”.

Price Performance Review of PTEN

On Monday, Patterson-UTI Energy Inc. [NASDAQ:PTEN] saw its stock fall -7.38% to $16.31. On the same session, the stock had its day’s lowest price of $16.24, but rose to a high of $18.10. Over the last five days, the stock has lost -4.62%. Patterson-UTI Energy Inc. shares have risen nearly 93.02% since the year began. Nevertheless, the stocks have risen 118.05% over the past one year. While a 52-week high of $20.53 was reached on 05/31/22, a 52-week low of $7.13 was recorded on 01/03/22. SMA at 50 days reached $16.04, while 200 days put it at $15.66. A total of 2.19 million shares were traded, compared to the trading of 1.24 million shares in the previous session.

Levels Of Support And Resistance For PTEN Stock

The 24-hour chart illustrates a support level at 15.67, which if violated will result in even more drops to 15.02. On the upside, there is a resistance level at 17.53. A further resistance level may holdings at 18.74. The Relative Strength Index (RSI) on the 14-day chart is 42.07, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.79, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 97.54%. Stochastics %K at 18.22% indicates the stock is a buying.

Patterson-UTI Energy Inc. [PTEN] – Who Are The Largest Shareholders?

In filings from BlackRock Fund Advisors, it is revealed that the company now owns 33,751,687 shares, or roughly 15.57% of the outstanding PTEN shares. In other words, the investor’s shares have risen by 210,494 from its previous 13-F filing of 33541193.0. Additionally, The Vanguard Group, Inc. increased 1.49% of its stake after which the total value it holdings stand at $444,260,243, while Macquarie Investment Management B added 3.21% of its stake to hold $245.12 million in the firm. Over the last quarter, Dimensional Fund Advisors LP purchased 534,785 shares of Patterson-UTI Energy Inc., while SSgA Funds Management, Inc. bought -103,714 shares. At present, Anomaly Capital Management LP is holding 7,566,464 shares valued at $133.55 million. Allspring Global Investments LLC owned 6,563,508 shares of the company at the time of its most recent 13F filing, worth $115.85 million.

According to FactSet, Patterson-UTI Energy Inc.’s share price will average $23.00 in the next year, based on opinions of analysts polled by the firm. This is up nearly 30.61 percent from its previous closing price of $17.61. Analysts expect Patterson-UTI Energy Inc. stock to reach the higher price of $26.00, while the lowest price estimate is $18.00. However, 15 analysts have rated PTEN stock as an Overweight in their predictions for 2022. The most recent change occurred on April 19, 2022 when The Benchmark Company began covering the stock and recommended ‘”a Buy”‘ rating along with a $21 price target.

Health Catalyst Inc. [HCAT] Chief People Officer makes an insider sale of 669 shares worth $7236.0.

0

Health Catalyst Inc.’s recent filing unveils that its Chief People Officer Llewelyn Linda unloaded Company’s shares for reported $7236.0 on Nov 15. In the deal valued at $10.82 per share,669 shares were sold. As a result of this transaction, Llewelyn Linda now holds 54,548 shares worth roughly $0.59 million.

Then, Burton Daniel D. bought 197,078 shares, generating $1,998,213 in total proceeds. Upon buying the shares at $10.14, the Chief Executive Officer now owns 900,140 shares.

Before that, Llewelyn Linda sold 648 shares. Health Catalyst Inc. shares valued at $6,175 were divested by the Chief People Officer at a price of $9.53 per share. As a result of the transaction, Llewelyn Linda now holds 55,217 shares, worth roughly $0.6 million.

Wells Fargo initiated its Health Catalyst Inc. [HCAT] rating to an Equal weight in a research note published on Monday, October 31, 2022; the price target was $10. PT values the company’s stock at a premium of -8.4 to its Monday closing price. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who decreased its forecast for the stock in late October from “an Outperform” to “a Sector perform”. KeyBanc Capital Markets began covering HCAT with “Sector weight” recommendation on September 16, 2022. Piper Sandler revised its rating on September 13, 2022. It rated HCAT as “a Neutral” which previously was an “an Overweight”.

Price Performance Review of HCAT

On Monday, Health Catalyst Inc. [NASDAQ:HCAT] saw its stock jump 1.69% to $10.84. On the same session, the stock had its day’s lowest price of $10.27, but rose to a high of $10.96. Over the last five days, the stock has gained 17.06%. Health Catalyst Inc. shares have fallen nearly -72.64% since the year began. Nevertheless, the stocks have fallen -72.13% over the past one year. While a 52-week high of $43.01 was reached on 01/03/22, a 52-week low of $6.40 was recorded on 11/08/22. SMA at 50 days reached $9.36, while 200 days put it at $15.28. A total of 0.6 million shares were traded, compared to the trading of 0.36 million shares in the previous session.

Levels Of Support And Resistance For HCAT Stock

The 24-hour chart illustrates a support level at 10.42, which if violated will result in even more drops to 10.00. On the upside, there is a resistance level at 11.11. A further resistance level may holdings at 11.38. The Relative Strength Index (RSI) on the 14-day chart is 61.13, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.68, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 6.00%. Stochastics %K at 87.67% indicates the stock is a selling.

How much short interest is there in Health Catalyst Inc.?

A steep rise in short interest was recorded in Health Catalyst Inc. stocks on Oct 13, 2022, growing by 0.22 million shares to a total of 2.75 million shares. Yahoo Finance data shows the prior-month short interest on Sep 14, 2022 was 2.53 million shares. There was a rise of 8.0%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 5.05% of the overall stock float, the days-to-cover ratio (short ratio) rose to 3.35.

Health Catalyst Inc. [HCAT] – Who Are The Largest Shareholders?

In filings from The Vanguard Group, Inc., it is revealed that the company now owns 5,863,298 shares, or roughly 10.71% of the outstanding HCAT shares. In other words, the investor’s shares have risen by 647,784 from its previous 13-F filing of 5215514.0. Additionally, BlackRock Fund Advisors decreased -2.72% of its stake after which the total value it holdings stand at $32,996,211, while Wellington Management Co. LLP reduced -7.07% of its stake to hold $22.17 million in the firm. Over the last quarter, Point72 Asset Management LP purchased 471,601 shares of Health Catalyst Inc., while Millennium Management LLC bought 1,323,571 shares. At present, Goldman Sachs Asset Management LP is holding 1,570,905 shares valued at $13.86 million. First Light Asset Management LLC owned 1,149,833 shares of the company at the time of its most recent 13F filing, worth $10.14 million.

According to FactSet, Health Catalyst Inc.’s share price will average $13.47 in the next year, based on opinions of analysts polled by the firm. This is up nearly 40.71 percent from its previous closing price of $10.66. Analysts expect Health Catalyst Inc. stock to reach the higher price of $17.00, while the lowest price estimate is $8.00. However, 17 analysts have rated HCAT stock as an Overweight in their predictions for 2022.

A company insider recently sold 3,042 shares of Travere Therapeutics Inc. [TVTX]. Should You also Consider to Sale?

In a filing, Travere Therapeutics Inc. revealed its Chief Commercial Officer Heerma Peter unloaded Company’s shares for reported $78119.0 on Oct 04. In the deal valued at $25.68 per share,3,042 shares were sold. As a result of this transaction, Heerma Peter now holds 65,148 shares worth roughly $1.3 million.

Then, Calvin Sandra sold 349 shares, generating $9,772 in total proceeds. Upon selling the shares at $28.00, the SVP, Chief Accounting Officer now owns 35,933 shares.

Before that, REED ELIZABETH E sold 1,050 shares. Travere Therapeutics Inc. shares valued at $22,584 were divested by the SVP, GC & Corporate Secretary at a price of $21.51 per share. As a result of the transaction, REED ELIZABETH E now holds 41,838 shares, worth roughly $0.84 million.

Wells Fargo initiated its Travere Therapeutics Inc. [TVTX] rating to an Overweight in a research note published on Monday, December 05, 2022; the price target was $28. PT values the company’s stock at a premium of 28.54 to its Monday closing price. A number of analysts have revised their coverage, including Bryan Garnier’s analysts, who began to cover the stock in late September with a ‘”a Sell”‘ rating. Piper Sandler started covering the stock on March 31, 2022. It rated TVTX as “an Overweight”.

Price Performance Review of TVTX

On Monday, Travere Therapeutics Inc. [NASDAQ:TVTX] saw its stock fall -0.35% to $20.01. On the same session, the stock had its day’s lowest price of $19.69, but rose to a high of $20.33. Over the last five days, the stock has gained 5.26%. Travere Therapeutics Inc. shares have fallen nearly -35.53% since the year began. Nevertheless, the stocks have fallen -27.53% over the past one year. While a 52-week high of $31.65 was reached on 01/03/22, a 52-week low of $18.70 was recorded on 11/29/22. SMA at 50 days reached $22.06, while 200 days put it at $24.68. A total of 0.65 million shares were traded, compared to the trading of 0.99 million shares in the previous session.

Levels Of Support And Resistance For TVTX Stock

The 24-hour chart illustrates a support level at 19.69, which if violated will result in even more drops to 19.37. On the upside, there is a resistance level at 20.33. A further resistance level may holdings at 20.65. The Relative Strength Index (RSI) on the 14-day chart is 43.96, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.16, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 65.16%. Stochastics %K at 31.29% indicates the stock is a holding.

How much short interest is there in Travere Therapeutics Inc.?

A steep rise in short interest was recorded in Travere Therapeutics Inc. stocks on Oct 13, 2022, dropping by -0.22 million shares to a total of 6.39 million shares. Yahoo Finance data shows the prior-month short interest on Sep 14, 2022 was 6.61 million shares. There was a decline of -3.44%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 10.03% of the overall stock float, the days-to-cover ratio (short ratio) fell to 7.79.

Travere Therapeutics Inc. [TVTX] – Who Are The Largest Shareholders?

In filings from Armistice Capital LLC, it is revealed that the company now owns 5,836,000 shares, or roughly 9.09% of the outstanding TVTX shares. In other words, the investor’s shares have risen by 516,000 from its previous 13-F filing of 5320000.0. Over the last quarter, BlackRock Fund Advisors sold -20,625 shares of Travere Therapeutics Inc., while Adage Capital Management LP sold 1,577,000 shares. At present, Janus Henderson Investors US LLC is holding 3,902,285 shares valued at $84.6 million. SSgA Funds Management, Inc. owned 3,413,415 shares of the company at the time of its most recent 13F filing, worth $74.0 million.

According to FactSet, Travere Therapeutics Inc.’s share price will average $32.73 in the next year, based on opinions of analysts polled by the firm. This is up nearly 74.3 percent from its previous closing price of $20.08. Analysts expect Travere Therapeutics Inc. stock to reach the higher price of $44.00, while the lowest price estimate is $17.00. However, 12 analysts have rated TVTX stock as an Overweight in their predictions for 2022. The most recent change occurred on February 28, 2022 when H.C. Wainwright began covering the stock and recommended ‘”a Buy”‘ rating along with a $45 price target.

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]